Related Experiment Video
Updated: Jul 18, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Left-dominant arrhythmogenic cardiomyopathy due to desmoplakin mutation: a case report
Gustavo A Lemus Barrios1,2, Jose P Lopez-Lopez1,2, Stephany Barbosa-Balaguera1,2
1Cardiology Unit, Hospital Universitario San Ignacio, Bogotá, Colombia.
Insights
A rare genetic mutation in the desmoplakin (DSP) gene caused arrhythmogenic cardiomyopathy in a patient presenting with acute heart failure. Genetic testing is crucial for diagnosing DSP-related heart conditions when other causes are ruled out.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Dilated cardiomyopathy presents with reduced left ventricular ejection fraction, requiring thorough etiological investigation.
- Differential diagnosis for heart failure includes hypertensive, ischemic, and valvular causes, which were excluded in this case.
Observation:
- Cardiac magnetic resonance imaging revealed global hypokinesis and subepicardial fibrosis.
- Exclusion of common causes of subepicardial fibrosis such as myocarditis, sarcoidosis, and Chagas disease was performed.
Findings:
- Genetic analysis identified a heterozygous mutation in the desmoplakin (DSP) gene (c.6697_6698del).
- This mutation led to a diagnosis of left-dominant DSP arrhythmogenic cardiomyopathy, characterized by structural myocardial abnormalities and ventricular arrhythmias.
Implications:
- Desmoplakin (DSP) gene mutations are implicated in up to 50% of arrhythmogenic cardiomyopathy cases.
- Genetic testing for DSP mutations should be considered in patients with unexplained dilated cardiomyopathy, especially when other common etiologies are ruled out.
Abstract:
The case of a 49-year-old man with acute onset of heart failure is presented. The initial work-up showed a dilated cardiomyopathy with severely reduced left ventricular ejection fraction. In the differential diagnostic process, hypertensive, ischaemic, and valvular aetiologies were discarded. Subsequently, a cardiac magnetic resonance revealed global hypokinesis and inferior and anterior subepicardial fibrosis. Once differential diagnoses of subepicardial fibrosis (myocarditis, sarcoidosis, and Chagas disease) were discarded, a genetic panel was performed, resulting in a heterozygous mutation of desmoplakin (DSP) gene c.6697_6698del. A left-dominant DSP arrhythmogenic cardiomyopathy mutation was diagnosed. Structural myocardial abnormalities and ventricular arrhythmias characterize arrhythmogenic cardiomyopathy. Up to 50% of cases are associated with mutations in DSP genes (JUP, DSP, and PKP2). DSP is the fundamental component of the desmosome structure and provides structural support through intercellular adhesion. Therefore, when frequent differential diagnoses are discarded, genetic studies for dilated cardiomyopathy and DSP mutation should be considered.
More Related Videos
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Desmosomes
Cardiomyopathy V: Interprofessional Care